Respiratory Syncytial Virus

Disease State Hub

Featured

Research Summary
Research Summary
10/01/2026
Ashton L. Stahl
A large US study found that two RSV prevention strategies, giving infants the antibody nirsevimab or vaccinating mothers during pregnancy, substantially reduced the risk of babies needing emergency or...
10/01/2026
Research Summary
Research Summary
09/21/2026
Anthony Calabro, MA
A prespecified DAN-RSV trial analysis found RSVpreF reduced RSV-related hospitalization regardless of heart failure status.
09/21/2026
Video
Video
08/28/2026
William Schaffner, MD
Dr. William Schaffner, MD, reviews evolving adult vaccination guidance and key opportunities to prevent severe disease in clinical practice.
08/28/2026

Interactive Features

3-in-30
3-in-30
10/29/2025
Anthony Calabro, MA
Test your knowledge of the latest Advisory Committee on Immunization Practices guidance, vaccine coadministration with influenza and respiratory syncytial virus shots, and state-level access changes. Three...
10/29/2025

Clinical Insights

Editorial
Editorial
08/24/2026
Ashton L. Stahl
Explore evolving vaccine science and policy, emerging influenza and RSV research, and expert insights to help clinicians navigate changing recommendations and support informed vaccination decisions across...
08/24/2026
Multidisciplinary Roundtable
Multidisciplinary Roundtable
08/27/2025
William Schaffner, MD; Tina Tan, MD, FIDSA, FPIDS, FAAP; Jennifer Walsh DNP, CPNP-PC, CNE
William Schaffner, MD; Tina Q. Tan, MD, FIDSA, FPIDS, FAAP; and Jennifer Walsh, DNP, CPNP, CNE, discuss the latest ACIP vaccine guideline updates for 2025–2026, including recommendations on influenza, RSV,...
08/27/2025
Conference Coverage
Conference Coverage
10/13/2024
Ashish Bhargava, MD
In this video, Ashish Bhargava, MD, discusses the results of his team's study on the risk factors associated with a longer hospital stay in adult patients with respiratory syncytial virus (RSV. He talks...
10/13/2024
Conference Coverage
Conference Coverage
05/02/2024
William Schaffner, MD
In this video, William Schaffner, MD, provides an overview of the topics presented at the 2023 Annual Conference on Vaccinology Research, hosted by the National Foundation for Infectious Diseases, including...
05/02/2024
Expert Q&A
Expert Q&A
03/18/2024
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
03/18/2024